Singapore markets open in 4 hours 18 minutes

Clínica Las Condes S.A. (LAS-CONDES.SN)

Santiago - Santiago Delayed price. Currency in CLP
Add to watchlist
15,815.00-27.00 (-0.17%)
As of 03:02PM CLT. Market open.
Currency in CLP

Valuation measures4

Market cap (intra-day) 132.69B
Enterprise value 313.16B
Trailing P/E 27.60
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.66
Price/book (mrq)0.50
Enterprise value/revenue 1.55
Enterprise value/EBITDA 217.33

Trading information

Stock price history

Beta (5Y monthly) -0.02
52-week change 32.29%
S&P500 52-week change 324.78%
52-week high 330,000.00
52-week low 314,000.00
50-day moving average 317,274.30
200-day moving average 317,931.43

Share statistics

Avg vol (3-month) 32.53k
Avg vol (10-day) 31.75k
Shares outstanding 58.38M
Implied shares outstanding 68.54M
Float 83.79M
% held by insiders 157.90%
% held by institutions 129.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4144.95
Forward annual dividend yield 40.91%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4856.67%
Dividend date 3N/A
Ex-dividend date 422 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -1.68%
Operating margin (ttm)18.18%

Management effectiveness

Return on assets (ttm)1.49%
Return on equity (ttm)-1.26%

Income statement

Revenue (ttm)202.26B
Revenue per share (ttm)24,148.32
Quarterly revenue growth (yoy)-15.10%
Gross profit (ttm)N/A
Net income avi to common (ttm)-3.4B
Diluted EPS (ttm)-405.56
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)17.67B
Total cash per share (mrq)2,110.16
Total debt (mrq)198.14B
Total debt/equity (mrq)74.19%
Current ratio (mrq)1.63
Book value per share (mrq)31,886.19

Cash flow statement

Operating cash flow (ttm)13.59B
Levered free cash flow (ttm)15.68B